Semaglutide weight loss before and after: what actually happens in the first six weeks

Step 1, Weeks one to two: appetite shifts before the scales do

The first pen contains semaglutide at its starter dose, 0.25mg weekly. That dose exists primarily to let the body adjust; nausea and gut discomfort are most likely in these early weeks, and the prescriber keeps the dose low on purpose. Most people report noticeably less hunger by the end of the first injection cycle, sometimes within days. The scales, though, often barely move yet. That is not a sign the medicine isn't working. Gastric emptying slows, meals feel satisfying with less food, and the brain's reward response to eating begins to change, but fat stores do not deplete overnight. People searching for dramatic before-and-after pictures at week two are almost always looking at the wrong marker.

Gastrointestinal side effects (nausea, loose stools, mild bloating) are common at this stage and typically settle within a week or two as the body acclimates. Staying hydrated and eating smaller meals helps. If symptoms are severe or persistent, the right move is to contact the prescribing team, not to skip doses independently. If you are also wondering how long semaglutide stays in your system after a missed or final dose, that is a separate but common question worth reading up on. The NHS semaglutide medicines page has a clear account of what to expect and when to seek help.

Step 2 (Weeks three to six: early weight reduction becomes measurable

By weeks three to six, most people on a stable 0.25mg dose begin to see a measurable drop on the scales) commonly one to three kilograms, occasionally more, depending on starting weight and how significantly food intake has reduced. The belly is one of the last places visceral fat moves from, not the first. If you have read about people seeing dramatic abdominal changes at the six-week mark, those accounts usually involve people who started at higher body weights, were already following a structured diet, or are simply not representative of the average experience.

The STEP 1 trial, published in the New England Journal of Medicine, followed 1,961 adults over 68 weeks and found average weight reduction of around 15% with semaglutide 2.4mg alongside lifestyle changes. Six weeks is roughly one-tenth of that study period. Putting week six in context: it is when the medicine is beginning to work, not when it has finished. Our page on six-week Wegovy results explores this timeline in more detail, including what participants in major trials reported at the early stages.

Step 3, What 'before and after' pictures don't show about six-week belly changes

Before-and-after photographs circulate widely on social media, usually captioned as Ozempic results. A few things those images rarely disclose: whether the person is on Ozempic or Wegovy, what dose they are on, whether they have diabetes (which changes both the licensed medicine and the clinical context), and what dietary or activity changes accompanied the medicine. Lighting, clothing and posture account for striking visual differences that have nothing to do with fat loss.

Belly fat (particularly the visceral kind that sits around the organs) does reduce with sustained weight loss on semaglutide. The evidence for this is solid. But six weeks is an early checkpoint, not a transformation window. Our page on semaglutide and belly fat looks at what the longer-term data actually shows. For a broader look at how results compare across time, semaglutide before and after covers the full picture.

Ozempic versus Wegovy: which semaglutide is licensed for weight loss in the UK?

This matters legally and clinically. Ozempic contains semaglutide at doses of 0.5mg, 1mg and 2mg; it is licensed in the UK for type 2 diabetes management, not for weight loss. Wegovy is the formulation licensed for weight management in UK adults with a BMI of 30 or above, or 27 or above with a weight-related health condition. Both are prescription-only medicines; both require clinical assessment before a prescription can be issued.

A UK prescriber operating within the licence will reach for Wegovy when the goal is weight management. Anyone offering you Ozempic specifically for weight loss without a diabetes diagnosis should prompt a question about why. For a full account of how Wegovy works, the dosing schedule and eligibility, our Wegovy treatment page is the place to start. If you are curious how quickly the medicine starts to produce results, how long Wegovy takes to work sets out a realistic week-by-week picture.

If you have been on semaglutide elsewhere and are thinking about switching provider, it is worth knowing that a reputable service will ask to see evidence of your current treatment before continuing at your existing dose. num gives a free consultation in which a GPhC-registered prescriber, not an algorithm, reads through your answers the same day. If you want to understand who oversees that clinical process, our clinical team page has the detail. And if you are ready to explore whether Wegovy or another licensed treatment suits your situation, starting a free consultation is the first step.